Academic Weakness Unexpectedly Hits Thermo Fisher's (TMO) Q3; FY11 Guidance Revised Down
Tweet Send to a FriendGet Alerts TMO Hot Sheet
Price: $86.18 +0.74%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade TMO Now!
Barclays Overweight Thermo Fisher Scientific (NYSE: TMO) price target cut from $64 to $58.
Barclays analyst says, "Moderating long-term sales outlook; EPS growth more resilient: In light of academic slowdown in Q3 and strong likelihood of weakness persisting in the near term, we expect initial FY12 organic sales growth guidance to come in below prior outlook of ~5% given at the analyst day. A low to mid single digit range, say 2-4%, appears to be reasonable at this point. That said, TMO remains focused on consistently delivering strong EPS growth, and we believe the company has a variety of operational levers to pull to meet mid-teens EPS growth expectations. We moderate our FY12 estimates (from $4.95 to $4.77)."
For more ratings news on Thermo Fisher Scientific click here and for the rating history of Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $48.36 yesterday, with a 52 week range of $47.77-$65.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Barclays analyst says, "Moderating long-term sales outlook; EPS growth more resilient: In light of academic slowdown in Q3 and strong likelihood of weakness persisting in the near term, we expect initial FY12 organic sales growth guidance to come in below prior outlook of ~5% given at the analyst day. A low to mid single digit range, say 2-4%, appears to be reasonable at this point. That said, TMO remains focused on consistently delivering strong EPS growth, and we believe the company has a variety of operational levers to pull to meet mid-teens EPS growth expectations. We moderate our FY12 estimates (from $4.95 to $4.77)."
For more ratings news on Thermo Fisher Scientific click here and for the rating history of Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $48.36 yesterday, with a 52 week range of $47.77-$65.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- UPDATE: UBS Starts Insmed (INSM) at Buy
- Wells Fargo Starts Quintiles (Q) at Outperform
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Barclays
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
